ALNY · Alnylam Pharmaceuticals, Inc. · Investor Relations
$246.74
-7.33 (-2.89%)
At close · Sep 30
Return incl. dividend (before tax)
Market Cap
$34.17B
Shares
133.81M
Volume · Sep 30
1.04M
Avg daily vol (3M)
1.8M
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-09-17 | Zilebesiran RNAi Roundtable | Event |
| 2026-09-14 | Morgan Stanley 24th Annual Global Healthcare Conference | Conference |
| 2026-09-08 | Wells Fargo 21st Annual Healthcare Conference | Conference |
| 2026-07-30 | Alnylam Pharmaceuticals Q2 2026 Earnings Conference Call | Earnings call |
| 2026-06-25 | RNAi Roundtable: ALN-6400, Targeting Plasminogen to Address Rare Bleeding Disorders | Event |
| 2026-06-09 | Goldman Sachs 47th Annual Global Healthcare Conference | Conference |
| 2026-05-13 | BofA Securities Healthcare Conference | Conference |
| 2026-04-30 | Q1 FY2026 Earnings conference call (announced in 8-K) | Earnings call |
| 2026-02-12 | Q4 Earnings conference call (announced in 8-K) | Earnings call |
Source: https://investors.alnylam.com/
Key facts
CIK
1178670
CUSIP
02043Q107
13F (30d)
20 filings
16 filers
Visit website
Investor relations